-IPS News Environmental activists are cautiously optimistic that a call by a court-appointed technical committee for a ten-year moratorium on open field trials of genetically modified (GM) crops will shelve plans to introduce bio-engineered foods in this largely agricultural country. “We are now waiting to see whether the Supreme Court will accept the recommendations of its own committee at the next hearing on Oct. 29,” said Devinder Sharma, chairman of the Forum...

-The Indian Express Almost three years after a genetically-engineered variety of brinjal (Bt brinjal) was put on indefinite hold — putting a question mark on the fate of genetically-modified crops in India — the government is making efforts make up for the time lost and put research in GM science back on track. In a fervent appeal to all chief ministers, some of whom have taken a public position against GM crops,...

-The Hindu India’s roads are deadlier than ever. The high rates of death and disability expose the lack of an organised system of traffic management and safety. Road safety is no one’s responsibility. It is time to make someone accountable. On the final day of this year’s ‘puja’ season in Chennai, a particular roadside temple near the iconic Central Railway Station had the long annual line of vehicles — vans, tempos, taxis,...

-The Hindu The Delhi High Court order dismissing a challenge to the Bus Rapid Transit System in the national capital is praiseworthy for its assertion that the urban commons, represented by road space, is a public good. The judgment correctly observes that governments pursue the principal purpose of promoting welfare of the maximum number of people, rather than distributing public goods in a restrictive manner. Delightfully, the court makes short work...

-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...